Works matching IS 09395555 AND DT 2005 AND VI 84 AND IP 9


Results: 17
    1

    Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.

    Published in:
    Annals of Hematology, 2005, v. 84, n. 9, p. 594, doi. 10.1007/s00277-005-1007-7
    By:
    • Schütt, Philipp;
    • Ebeling, Peter;
    • Buttkereit, Ulrike;
    • Brandhorst, Dieter;
    • Opalka, Bertram;
    • Poser, Miriam;
    • Müller, Siemke;
    • Flasshove, Michael;
    • Moritz, Thomas;
    • Seeber, Siegfried;
    • Nowrousian, Mohammad
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group

    Published in:
    Annals of Hematology, 2005, v. 84, n. 9, p. 557, doi. 10.1007/s00277-005-1046-0
    By:
    • Wrzesień-Kuś, A.;
    • Robak, T.;
    • Wierzbowska, A.;
    • Lech-Marańda, E.;
    • Pluta, A.;
    • Wawrzyniak, E.;
    • Krawczyńska, A.;
    • Kuliczkowski, K.;
    • Mazur, G.;
    • Kiebiński, M.;
    • Dmoszyńska, A.;
    • Wach, M.;
    • Hellmann, A.;
    • Baran, W.;
    • Hołowiecki, J.;
    • Kyrcz-Krzemień, S.;
    • Grosicki, S.
    Publication type:
    Article
    11
    12
    14
    15
    16
    17